An Observational Study of Local Relapse After High Grade Osteosarcoma
Recruiting now
Conditions studied: Osteosarcoma
In brief
multicenter retrospective and prospective study in patients with high-grade osteosarcoma
Key facts
- Study ID
- NCT06017518
- Run by
- Istituto Ortopedico Rizzoli
- People needed
- 150
- Starts
- 2022-06-13
- Expected to finish
- 2026-06-30
- Last updated by the study team
- 2025-09-22
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients who experienced LR as first event of recurrence after treatment for localized high-grade osteosarcoma of bone, including cases with synchronous lung metastases
- Adequate patient compliance to follow-up visits
- Written informed consent prior to any study-specific analysis and/or data collection
- No age limits
You may not qualify if…
- Cases of LR demonstrated after > 3 months after metastatic disease
- Impossibility to ensure adequate compliance
Where it is running
- IRCCS Istituto Ortopedico Rizzoli — Bologna, BO, Italy (enrolling)
- Azienda Ospedaliero-Universitaria Pisana — Pisa, PI, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.